首页> 美国卫生研究院文献>Cell Death Disease >The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicity
【2h】

The purinergic P2Y14 receptor axis is a molecular determinant for organism survival under in utero radiation toxicity

机译:嘌呤能P2Y14受体轴是子宫内辐射毒性下生物存活的分子决定因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In utero exposure of the embryo and fetus to radiation has been implicated in malformations or fetal death, and often produces lifelong health consequences such as cancers and mental retardation. Here we demonstrate that deletion of a G-protein-coupled purinergic receptor, P2Y14, confers potent resistance to in utero radiation. Intriguingly, a putative P2Y14 receptor ligand, UDP-glucose, phenocopies the effect of P2Y14 deficiency. These data indicate that P2Y14 is a receptor governing in utero tolerance to genotoxic stress that may be pharmacologically targeted to mitigate radiation toxicity in pregnancy.
机译:在子宫内,胚胎和胎儿受到放射线照射可能导致畸形或胎儿死亡,并经常产生终身健康后果,例如癌症和智力低下。在这里,我们证明删除G蛋白偶联的嘌呤能受体P2Y14赋予子宫内辐射强大的抵抗力。有趣的是,推定的P2Y14受体配体UDP-葡萄糖表型反映了P2Y14缺乏的影响。这些数据表明,P2Y14是控制子宫内对基因毒性压力的耐受性的受体,在药理学上可将其靶向以减轻怀孕期间的放射毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号